Andrew Jakymiw, Ph.D.
Dr. Jakymiw's research focuses on the study of RNA interference (RNAi)-based therapies for oral cancer. In particular, his lab is currently involved in developing peptide carrier-mediated targeted delivery strategies of therapeutic small interfering RNA (siRNA) molecules for the treatment of oral cancer. The goal of his research is to advance peptide carrier designs for siRNA delivery in order to develop a clinically relevant peptide carrier-mediated siRNAi-based drug treatment strategy for human oral cancer.
Faculty Directory Information for Dr. Jakymiw can be found by following this link.
Subramanya Pandruvada, Ph.D.
Dept of Oral Health Sciences
College of Dental Medicine
My research focuses on osteoimmunological aspects involved in periodontal disease; and cancer cell signaling with a particular interest in the biology and regulation of protein-tyrosine phosphatases in the development of malignancy and therapeutic resistance in breast and head and neck cancers.
Dr. Ozlem Yilmaz, D.D.S., Ph.D.